Does Nifedipine Decrease Transmural Dispersion of Repolarization (TDR)?
Yes, nifedipine can decrease transmural dispersion of repolarization at appropriate doses, specifically by selectively reducing epicardial action potential duration while preserving endocardial repolarization, thereby restoring normal transmural gradients.
Mechanism and Evidence
The most compelling evidence comes from experimental cardiac electrophysiology demonstrating that 1 micromolar nifedipine selectively reduced epicardial APD90 (from 66.1 ± 3.4 to 46.2 ± 2.5 ms) without affecting endocardial APD90, thereby restoring the transmural APD gradient (ΔAPD90) from an abnormal -5.9 ± 2.5 ms to a near-normal 15.5 ± 3.2 ms 1. This restoration of normal transmural gradients occurred while simultaneously eliminating early afterdepolarizations (EADs) and ventricular tachycardia in hypokalaemic hearts.
Dose-Dependent Effects
The antiarrhythmic benefit is concentration-dependent:
- 10 nM nifedipine: No significant effect on EADs or transmural dispersion
- 100 nM nifedipine: Reduced EADs and triggered beats but did not normalize transmural gradients
- 1 μM nifedipine: Completely abolished EADs, triggered beats, and spontaneous VT while normalizing transmural dispersion 1
Clinical Context from Guidelines
The AHA/ACC scientific statement provides important context: verapamil, another potent IKr blocker and L-type calcium channel blocker like nifedipine, has never been associated with torsades de pointes, likely because it blocks L-type calcium channels more potently than it prolongs repolarization 2. This same protective mechanism applies to nifedipine—its calcium channel blocking properties counterbalance any potential pro-arrhythmic effects from repolarization changes.
Mechanistic Rationale
Nifedipine's beneficial effect on TDR stems from:
- Selective epicardial effects: L-type calcium channels contribute more significantly to epicardial action potential duration than endocardial duration
- Reduction of calcium-dependent afterdepolarizations: By blocking L-type calcium channels, nifedipine prevents the calcium overload that generates EADs
- Normalization of transmural gradients: The selective epicardial shortening restores the physiologic epicardial-to-endocardial repolarization sequence
Important Caveats
- The beneficial effects on TDR occur at specific therapeutic concentrations; subtherapeutic doses may be ineffective
- The FDA labeling notes that nifedipine has no tendency to prolong atrioventricular conduction, slow sinus rate, or cause significant electrophysiologic disturbances in formal studies 3
- While nifedipine decreases TDR, this does not mean it should be used as an antiarrhythmic agent—its primary indication remains hypertension and angina
Contrast with Pro-Arrhythmic Drugs
Unlike selective IKr blockers that increase TDR by preferentially prolonging mid-myocardial (M cell) repolarization, nifedipine's multichannel effects (blocking both depolarizing calcium currents and affecting repolarization) prevent the development of arrhythmogenic substrate 1. This aligns with theoretical models suggesting that multichannel pharmacology can prolong APD while minimizing dispersion 4.